John Gordan

MD

Gastrointestinal oncologist

About me

Dr. John Gordan is a gastrointestinal cancer specialist at UCSF Medical Center's Gastrointestinal Medical Oncology Clinic. He cares for patients with hepatobiliary cancers, such as cholangiocarcinoma (bile duct cancer), hepatocellular carcinoma (the most common liver cancer) and gallbladder cancer.

Gordan is actively involved in designing and carrying out clinical trials of potential treatments for hepatocellular carcinoma and cholangiocarcinoma. His laboratory research focuses on identifying new therapies for patients with these cancers as well as identifying predictive biomarkers to better apply existing therapies.

Gordan completed his medical degree at the University of Pennsylvania, followed by a residency in internal medicine and a fellowship in medical oncology at UCSF. He joined the UCSF faculty in 2015.

Gordan is a member of the American Society of Clinical Oncology, which supports his research, as does the American Cancer Society.

  • Education

    University of Pennsylvania School of Medicine, 2009

  • Residencies

    UCSF Medical Center, 2011

  • Fellowships

    UCSF Medical Center, 2014

  • Board Certifications

    Internal Medicine, American Board of Internal Medicine

Gastrointestinal Medical Oncology Clinic

Bakar Precision Cancer Medicine Building

1825 Fourth St., Fourth Floor
San Francisco, CA 94158

My reviews

5.0

Overall Experience
51 Reviews
Dr. Gordan is forthright caring and explains all. His attention to my care and treatment is reassuring. I would recommend him to any and everyone with a GI cancer. I am grateful to be in his hands.
Explained things in a way that was easy to understand
51 Reviews
Did the doctor pay attention to your concerns
50 Reviews
Gave easy to understand instructions about taking care of health problems or concerns
51 Reviews
Knew the important information about your medical history
51 Reviews
The provider showed respect for what you had to say
51 Reviews
The provider spent enough time with me
51 Reviews

Share